Study questions effectiveness of adjunctive HBOT for DFUs

A recent study in Diabetes Care casts doubt on the efficacy of hyperbaric oxygen therapy for reducing amputation risk in patients with diabetes although several physicians disagree with that assessment. The prospective, double-blind, randomized controlled clinical trial included patients with diabetes who had foot lesions for at least four weeks.

A recent study in Diabetes Care casts doubt on the efficacy of hyperbaric oxygen therapy for reducing amputation risk in patients with diabetes although several physicians disagree with that assessment. The prospective, double-blind, randomized controlled clinical trial included patients with diabetes who had foot lesions for at least four weeks.

Read this article:
Study questions effectiveness of adjunctive HBOT for DFUs